Private profits versus public policy : the pharmaceutical industry and the Canadian state /

Mostrar otras versiones (1)

"The widespread condemnation of drastic price increases on life-saving drugs highlights our growing dependency on and vulnerability to international pharmaceutical conglomerates. However, aren't the interests of the public supposed to supersede the pursuit of private profit? In his new wor...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Lexchin, Joel, 1948- (Autor)
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Toronto ; Buffalo ; London : University of Toronto Press, [2016]
Temas:
Pharmaceutical industry > Government policy > Canada.
Drug development > Government policy > Canada.
Prescription pricing > Government policy > Canada.
Profit > Government policy > Canada.
Industrie pharmaceutique > Politique gouvernementale > Canada.
Médicaments > Développement > Politique gouvernementale > Canada.
Médicaments > Prix > Politique gouvernementale > Canada.
Profit > Politique gouvernementale > Canada.
BUSINESS & ECONOMICS > Industries > General.
HEALTH & FITNESS / Health Care Issues
Pharmaceutical industry > Government policy
Prescription pricing > Government policy
Profit > Government policy
Canada
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Introduction : why do we care about the pharmaceutical industry in Canada?
  • (De)regulation through cooperation
  • Biased testing, hidden results, and the regulation of clinical trials
  • Approving new drugs : better or just more?
  • Regulating promotion or licensing deception?
  • Health Canada and drug safety : how safe are we?
  • Is intellectual property a right?
  • How revenue is generated : prices, volume, mix, and overall spending
  • Who gets the value from research and development?
  • Canada, the pharmaceutical industry, and access to medicines in the global south
  • Courage, my friends; 'tis not too late to build a better world.

Ejemplares similares